Second- and third-line treatment strategies in multiple myeloma: a referral-center experience

Second- and third-line treatment strategies in multiple myeloma: a referral-center experience

Abstract The treatment landscape for relapsed multiple myeloma (MM) has increased. In this study, we aimed to characterize 2nd (n = 1439) and 3rd (n = 1104) line regimens and compare the results between subgroups based on the year of treatment initiation (2nd line: 2003–2008, 2009–2015, 2016–2021; 3...

Full description

Bibliographic Details
Main Authors: Sarah Goldman-Mazur, Alissa Visram, S. Vincent Rajkumar, Prashant Kapoor, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Taxiarchis Kourelis, Wilson Gonsalves, Rahma Warsame, Eli Muchtar, Nelson Leung, Robert A. Kyle, Shaji K. Kumar
Format: Article
Language:English
Published: Nature Publishing Group 2022-12-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-022-00757-8

Internet

https://doi.org/10.1038/s41408-022-00757-8

Similar Items